Register for an account


Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.


Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.


New Drug Treats Congenital Blindness

New treatment improves vision in those with an inherited eye disease.

By Connor WaltersJanuary 22, 2015 10:59 PM
Robert Koenekoop tests a child’s eyesight at the McGill University Health Center in Montreal. | Daniel Héon/McGill University Health Center


Sign up for our email newsletter for the latest science news

A new oral drug can improve vision in people with a specific form of blindness, researchers announced in July.

A team led by pediatric ophthalmologist Robert Koenekoop at McGill University gave the medication to 14 patients with Leber congenital amaurosis, an inherited disease that causes retinal degeneration leading to blindness. Ten of the patients, both children and adults, saw their visual field expand, and six experienced improved visual acuity, according to the team’s study, published in The Lancet.

“This is very exciting; we could possibly provide treatment for these disorders that until very recently were considered untreatable,” says Janine Mendola, a McGill neuroscientist involved in the study.

[This article originally appeared in print as "Sight, Seen."]

3 Free Articles Left

Want it all? Get unlimited access when you subscribe.


Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 50%


Already a subscriber? Register or Log In